Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-155-9 | CAS number: 78-90-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
oral: LD50 = ca. 1300 mg/kg bw (pre-GLP study similar to OECD 401 in male and female rats);
inhalation: LC50 (8 h exposure) > 49 mg/L air (pre-GLP, IRT in male and female rats);
dermal: LD50 = 430 mg/kg bw (pre-GLP study according to the one-day cuff method of Draize and associates, rabbit)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14 Dec 1965 - 11 Jan 1966
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- The study was conducted according to an internal BASF method which in principle is comparable to the OECD Guideline 401. A test group consisting of 5 animals/sex was treated by single gavage application with an aqueous solution of the test substance. The animals were observed for mortality and for clinical symptoms of toxicity. At the end of the observation period of 14 days, the surviving animals were sacrificed for the purpose of necropsy; animals that died during the observations period also were subjected to necropsy. The LD50 value was estimated on the basis of the observed mortalities.
- GLP compliance:
- no
- Limit test:
- no
- Species:
- rat
- Strain:
- other: US-rats
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: male: 235 - 305 g; female: 124- 206 g - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Aqua dest.
- Concentration in vehicle: 2 % and 20 % - Doses:
- 200, 800, 1000, 1250, 1600, 3200 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 12-14 days
- Frequency of observations: daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 1 300 mg/kg bw
- Mortality:
- Observed; for details please refer to "Any other information on results incl. tables".
- Clinical signs:
- other: Staggering, prone and side positions, intermittent respiraton, ruffled fur.
- Gross pathology:
- Animals that died: gastrorectasis and corrosion.
Sacrificed animals: no abnormalities. - Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 for oral acute toxicity in rats was calculated as 1.5 ml/kg bw which corresponds to ca. 1300 mg/kg bw based on the density 0.86 g/cm3 .
- Executive summary:
In a study which was in large parts equivalent to methods described in OECD guideline 401, doses of 200, 800, 1000, 1250, 1600, 3200 mg/kg bw of an aqueous solution of the test substance were applied by gavage to male and female US-rats (5 animals per sex per dose). The animals were observed for mortality and for clinical symptoms of toxicity. At the end of the observation period of 14 days, the surviving animals were sacrificed for the purpose of necropsy; animals that died during the observation period also were subjected to necropsy. Mortality occurred at doses of 800 mg/kg bw and higher. At 3200 mg/kg bw all animals died within 24 h. The main clinical signs were staggering, prone and side positions, intermittent respiration and ruffled fur. At necropsy, gastrorectasis and corrosion effects were observed in animals that died during the observation period.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Principles of method if other than guideline:
- Single oral dose toxicity was estimated by the gastric intubation of groups of five non-fasted, rats four to five weeks of age and 90 to 120 grams. The dosages were arranged in a logarithmic series differing by a factor of two. Whenever possible, the chemical was administered undiluted. Based upon mortalities during a 14-day observation period, the most probable LD50 value and its fiducial range were estimated by the method of Thompson.
- GLP compliance:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Doses:
- no data
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 230 mg/kg bw
- 95% CL:
- 1 900 - 2 620
- Mortality:
- no data
- Clinical signs:
- other: no data
- Gross pathology:
- no data
- Interpretation of results:
- Category 5 based on GHS criteria
Referenceopen allclose all
Mortality:
Dose (mg/kg bw) | conc. (%) | Gender | 1 h | 24 h | 48 h | day 7 | day 14 |
3200 | 20 | male | 0/5 | 5/5 | 5/5 | 5/5 | 5/5 |
3200 | 20 | female | 0/5 | 5/5 | 5/5 | 5/5 | 5/5 |
1600 | 20 | male | 0/5 | 2/5 | 2/5 | 2/5 | 2/5 |
1600 | 20 | female | 0/5 | 4/5 | 4/5 | 4/5 | 4/5 |
1250 | 20 | male | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
1250 | 20 | female | 0/5 | 3/5 | 3/5 | 3/5 | 3/5 |
1000 | 20 | male | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
1000 | 20 | female | 0/5 | 1/5 | 1/5 | 1/5 | 1/5 |
800 | 20 | male | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
800 | 20 | female | 0/5 | 1/5 | 1/5 | 1/5 | 1/5 |
200 | 2 | male | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
200 | 2 | female | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
The application of the test substance caused toxicity (including mortality) in a dose dependent matter.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 300 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Principles of method if other than guideline:
- BASF-Test. The test demonstrates the toxicity of an atmosphere saturated with vapours of the volatile components of the test substance at the temperature chosen for vapour generation (20 °C). 3 rats per sex were exposed sequentially to the vapours, generated by bubbling 200 l/h air through a substance column of about 5 cm above a fritted glassdisc in a glass cylinder for 30 min,1 h, 2 h and 2.5 h. For a 8 h exposure a desiccator was used as exposure chamber.The documentation of clinical signs was performed over a period of 14 days.
- GLP compliance:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 210 g (mean) - Route of administration:
- inhalation: mixture of vapour and aerosol / mist
- Type of inhalation exposure:
- nose/head only
- Remarks:
- except 8h exposure, which was a whole body exposure
- Vehicle:
- air
- Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- > 0.5 - < 8 h
- Remarks on duration:
- several exposure times: 30min, 1 h, 2 h, 2.5 h and 8 h
- Concentrations:
- 30 min exposure: 26 mg/L air
1 h exposure: 30 mg/L air
2 h exposure: 26 mg/L air
2.5 h exposure: 25,2 mg/L air
8 h exposure: 18 mg/L air, 49 mg/L air
Nominal concentrations based on the substance loss. - No. of animals per sex per dose:
- 30 min exposure: 3
1 h exposure: 3
2 h exposure: 6
2.5 h exposure: 3
8 h exposure: 6 - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: several times on the day of exposure and daily afterwards.
- Frequency of weighing: before the treatment and at the end of the observation period.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 49 mg/L air
- Exp. duration:
- 8 h
- Remarks on result:
- other: theoretical saturated vapour concentration is 32.8mg/L. Higher value likely results from substance loss in the experimental setup describes as severe fogging.
- Mortality:
- 30 min exposure: 0/6 (head/nose only)
1 h exposure: 0/6 (head/nose only)
2 h exposure: 2/12 (head/nose only)
2.5 h exposure: 2/6 (head/nose only)
8 h exposure: 0/12 (whole body, exsikkator) - Clinical signs:
- other: At the beginning of the test: impetuous attempts to escape, bloody eye and nose discharge, severe irritation of mucous membranes. During the post exposure period: severe corrosion of the exposed tissues (face, eyes, fore limbs).
- Body weight:
- The surviving animals gained weight
- Gross pathology:
- 2.5 h exposure: pulmonary emphysema in one animal
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- No mortality was observed after an 8-h exposure at the saturated vapour concentration.
- Executive summary:
To evaluate the acute toxicity after inhalation an inhalation risk test was conducted. Male and female rats (strain not specified) were exposed to vapours of the test substance for various exposure durations (30 min, 1 h, 2 h, 2.5 h, 8 h). The vapours were generated by bubbling air through a column which contained the test substance. The vapour concentrations were calculated based on the substance loss.
At the beginning of the exposure the animals showed impetuous attempts to escape. Bloody eye and nose discharge and severe dyspnea and reduced breathing were observed during the exposure duration.
After the exposure period the animals developed severe corrosion of the exposed tissues (face, eyes, fore limbs). Two animals of the 2-h and the 2.5 -h exposure group died within 4 days after exposure (head/nose only, app. 25mg/L)
No mortality was observed after an 8-h exposure (whole body, 49mg/L).
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Principles of method if other than guideline:
- Concentrated vapor inhalation consisted of subjecting groups of six male albino rats to a flowing stream of vapour-ladened air. The vapour-air mixture was generated by passing dried air at room temperature through a gas-washing bottle. Inhalations were continued for time periods in a logarithmic series with a ratio of two extending to eight hours, until the inhalation period killing about half the number of rats within 14 days is defined.
- GLP compliance:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- not specified
- Vehicle:
- air
- Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- 4 h
- Concentrations:
- saturated vapour
(calculated by registrant as 32.8mg/L) - No. of animals per sex per dose:
- 6
- Control animals:
- not specified
- Sex:
- not specified
- Dose descriptor:
- LC50
- Effect level:
- > 32.8 mg/L air
- Based on:
- other: theoretic saturated vapour concentration (calculated)
- Exp. duration:
- 4 h
- Mortality:
- none
- Body weight:
- no data
- Gross pathology:
- no data
- Interpretation of results:
- GHS criteria not met
Referenceopen allclose all
The inhalation of a highly saturated vapor-air-mixture caused mortality after 2 h of exposure. The substance caused severe corrosion at exposed tissues.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- 49 000 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Principles of method if other than guideline:
- Penetration of rabbit skin was estimated by a technique closely to the one-day cuff method of Draize and associates, using groups of four male albino rabbits weighing 2.5 to 3.5 kg. The fur was removed from the entire trunk by clipping, and the dose was retained beneath an impervious plastic film. The animals were immobilized during the 24 hour contact period, after which the film was removed and the rabbits were caged for the subsequent 14 day observation period.
- GLP compliance:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male
- Type of coverage:
- occlusive
- Vehicle:
- not specified
- Duration of exposure:
- 24 h
- Doses:
- no data
- No. of animals per sex per dose:
- 4
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 430 mg/kg bw
- Remarks on result:
- other: conversion into mg/kg is based on the density of 0.86 g/cm3 (according to BASF internal data).
- Mortality:
- no data
- Clinical signs:
- other: no data
- Gross pathology:
- no data
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- A dermal LD50 value for propylenediamine of 0.5 ml/kg bw, equivalent to 430 mg/kg bw (based on a density of 0.86 g/cm³) was reported for rabbits.
- Executive summary:
Penetration of rabbit skin was estimated by a technique closely to the one-day cuff method of Draize and associates, using groups of four male albino rabbits weighing 2.5 to 3.5 kg. The fur was removed from the entire trunk by clipping, and the dose was retained beneath an impervious plastic film. The animals were immobilized during the 24 hour contact period, after which the film was removed and the rabbits were caged for the subsequent 14 day observation period. No data regarding mortality, clinical signs and body weight changes are given. The reported LD50 for the penetration of rabbit skin is 0.5 ml/kg bw.
Reference
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 430 mg/kg bw
Additional information
Oral:
In a study which was in large parts equivalent to methods described in OECD guideline 401, the LD50 for oral acute toxicity in rats was calculated as ca. 1300 mg/kg body weight. Doses of 200, 800, 1000, 1250, 1600 and 3200 mg/kg bw of an aqueous solution of the test substance were applied by gavage to male and female US-rats (5 animals per sex per dose) followed by a post dose observation period of 14 days.
Mortality occurred at doses of 800 mg/kg bw and higher. At 3200 mg/kg bw all animals died within 24 h. The main clinical signs were staggering, prone and side positions, intermittent respiraton and ruffled fur. At necropsy, gastrorectasis and corrosion effects were observed in animals that died during the observation period. The LD50 for oral acute toxicity in rats was calculated as 1.5 ml/kg bw which corresponds to ca. 1300 mg/kg bw based on the density 0.86 g/cm3.
In a further study with only limited data provided, the test substance caused likewise moderate toxicity after a single ingestion (LD50 = 2230 mg/kg bw).
Inhalation:
Data is available from an inhalation risk test (IRT) which meets generally accepted scientific principles. Male and female rats (strain not specified) were exposed to vapours of the test substance for various exposure durations (30 min, 1 h, 2 h, 2.5 h, 8 h). The vapours were generated by bubbling air through a column which contained the test substance. The vapour concentrations were calculated based on the substance loss. At the beginning of the exposure the animals showed impetuous attempts to escape. Bloody eye and nose discharge and severe dyspnea and reduced breathing were observed during the exposure duration.
After the exposure period the animals developed severe corrosion of the exposed tissues (face, eyes, fore limbs). Two animals of the 2-h and the 2.5 -h exposure group died within 4 days after exposure (head/nose only, app. 25mg/L). No mortality was observed after an 8 -h exposure to a vapour concentration of 49 mg/L air (whole body). Therefore, the LC50 was not reached at saturated vapour concentrations.
Smyth et al. also reported no mortalities in rats after 4h exposure to the saturated vapour concentration.
Dermal:
Penetration of rabbit skin was estimated by a technique closely to the one-day cuff method of Draize and associates, using groups of four male albino rabbits weighing 2.5 to 3.5 kg. The fur was removed from the entire trunk by clipping, and the dose was retained beneath an impervious plastic film. The animals were immobilized during the 24 hour contact period, after which the film was removed and the rabbits were caged for the subsequent 14 day observation period. No data regarding mortality, clinical signs and body weight changes are given.
A dermal LD50 value for propylenediamine of 0.5 ml/kg bw, equivalent to 430 mg/kg bw (based on a density of 0.86 g/cm3) was reported for rabbits, with no further details provided.
Justification for classification or non-classification
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance has to be classified for acute oral toxicity cat. 4 and acute dermal toxicity cat. 3 under Regulation (EC) No. 1272/2008, as amended for the 13th time in Regulation (EU) 2018/1480.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
